drugset
drugset / Trial / NCT02128100

Effects of Folfirinox and Stereotactic Body Radiation Therapy for Advanced Pancreatic Cancer

NCT02128100 ↗

Phase 2 Completed 5 enrolled University of Louisville James Graham Brown Cancer Center · collab
NaSingle-groupOpen-labelTreatment

Summary

This study wants to find out how safe and effective the use of Folfirinox combined with Stereotactic Body Radiation Therapy )(SBRT) is for the treatment of pancreatic cancer.

Timeline

Start
2014-09-19
Primary completion
2021-03-15
Completion
2021-03-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Irinotecan Small molecule 180 mg/m2 —
Subject Leucovorin Small molecule 400 mg/m2 —
Subject Oxaliplatin Small molecule 85 mg/m2 —
Subject fluorouracil Small molecule 400 mg/m2 —
Subject fluorouracil Small molecule 2400 mg/m2 —

Indications

malignant pancreatic neoplasm